Virulizin®
LOR/VIR/P03/002
Phase 3 small_molecule completed
Quick answer
Virulizin® for Pancreatic Cancer is a Phase 3 program (small_molecule) at Aptose Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aptose Biosciences
- Indication
- Pancreatic Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed